Documents P-selectin may reduce myocardial damage during PCI in non-STEMI patients

1. The SELECT-ACS Trial Effects of the P-selectin antagonist inclacumab on myocardial damage after PCI for NSTEMI Jean-Claude Tardif MD Montreal Heart Institute University…